Publications by authors named "Matthew Dankner"

12Publications

Invasive growth associated with Cold-Inducible RNA-Binding Protein expression drives recurrence of surgically resected brain metastases.

Authors:
Matthew Dankner Maxime Caron Tariq Al-Saadi WenQing Yu Veronique Ouellet Rima Ezzeddine Sarah M Maritan Matthew G Annis Phuong Uyen Le Javad Nadaf Noah S Neubarth Paul Savage Dongmei Zuo Charles P Couturier Jean Monlong Haig Djambazian Huda Altoukhi Guillaume Bourque Jiannis Ragoussis Roberto J Diaz Morag Park Marie-Christine Guiot Stephanie Lam Kevin Petrecca Peter M Siegel

Neuro Oncol 2021 Jan 12. Epub 2021 Jan 12.

Division of Experimental Medicine, Montréal, Québec, Canada.

View Article and Find Full Text PDF
January 2021

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors.

Authors:
Paul Savage Alain Pacis Hellen Kuasne Leah Liu Daniel Lai Adrian Wan Matthew Dankner Constanza Martinez Valentina Muñoz-Ramos Virginie Pilon Anie Monast Hong Zhao Margarita Souleimanova Matthew G Annis Adriana Aguilar-Mahecha Josiane Lafleur Nicholas R Bertos Jamil Asselah Nathaniel Bouganim Kevin Petrecca Peter M Siegel Atilla Omeroglu Sohrab P Shah Samuel Aparicio Mark Basik Sarkis Meterissian Morag Park

Commun Biol 2020 Jun 16;3(1):310. Epub 2020 Jun 16.

Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.

View Article and Find Full Text PDF
June 2020

An exercise in scientific writing for physicians in training.

Authors:
Heather T Whittaker Lashanda Skerritt Matthew Dankner Mark J Eisenberg

Clin Invest Med 2020 Apr 5;43(1):E35-E38. Epub 2020 Apr 5.

Division of Cardiology, Jewish General Hospital, McGill University, Montréal, QC.

View Article and Find Full Text PDF
April 2020

Post-mortem tissue donation programs as platforms to accelerate cancer research.

Authors:
Matthew Dankner Badia Issa-Chergui Nathaniel Bouganim

J Pathol Clin Res 2020 07 21;6(3):163-170. Epub 2020 Mar 21.

Division of Oncology, McGill University, Quebec, Canada.

View Article and Find Full Text PDF
July 2020

p66ShcA functions as a contextual promoter of breast cancer metastasis.

Authors:
Kyle Lewis Alex Kiepas Jesse Hudson Julien Senecal Jacqueline R Ha Elena Voorand Matthew G Annis Valerie Sabourin Ryuhjin Ahn Rachel La Selva Sébastien Tabariès Brian E Hsu Matthew J Siegel Matthew Dankner Eduardo Cepeda Canedo Mathieu Lajoie Ian R Watson Claire M Brown Peter M Siegel Josie Ursini-Siegel

Breast Cancer Res 2020 01 15;22(1). Epub 2020 Jan 15.

Lady Davis Institute for Medical Research, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC, H3T 1E2, Canada.

View Article and Find Full Text PDF
January 2020

CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.

Authors:
Matthew Dankner Véronique Ouellet Laudine Communal Estelle Schmitt Dru Perkins Matthew G Annis Véronique Barrès Christine Caron Anne-Marie Mes-Masson Fred Saad Peter M Siegel

Am J Pathol 2019 07 12;189(7):1451-1461. Epub 2019 Jun 12.

Goodman Cancer Research Centre, Department of Medicine, McGill University, Montréal, Québec, Canada. Electronic address:

View Article and Find Full Text PDF
July 2019

BRAF Mutation Class and Clinical Outcomes-Letter.

Authors:
Matthew Dankner April A N Rose

Clin Cancer Res 2019 05;25(10):3188

Faculty of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
May 2019

Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas.

Authors:
Matthew Dankner Mathieu Lajoie Dan Moldoveanu Tan-Trieu Nguyen Paul Savage Shivshankari Rajkumar Xiu Huang Maria Lvova Alexei Protopopov Dana Vuzman David Hogg Morag Park Marie-Christine Guiot Kevin Petrecca Catalin Mihalcioiu Ian R Watson Peter M Siegel April A N Rose

Clin Cancer Res 2018 12 14;24(24):6483-6494. Epub 2018 Jun 14.

Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
December 2018

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy.

Authors:
Cynthia Bernier Ahmed Soliman Michel Gravel Matthew Dankner Paul Savage Kevin Petrecca Morag Park Peter M Siegel Gordon C Shore Anne Roulston

Anticancer Drugs 2018 09;29(8):774-785

Laboratory for Therapeutic Development.

View Article and Find Full Text PDF
September 2018

Comment on 'Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study'.

Authors:
Matthew Dankner April A N Rose

Br J Cancer 2018 05 22;118(9):1276-1277. Epub 2018 Mar 22.

Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF
May 2018

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

Authors:
Matthew Dankner April A N Rose Shivshankari Rajkumar Peter M Siegel Ian R Watson

Oncogene 2018 06 15;37(24):3183-3199. Epub 2018 Mar 15.

Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada.

View Article and Find Full Text PDF
June 2018

CEACAM1 as a multi-purpose target for cancer immunotherapy.

Authors:
Matthew Dankner Scott D Gray-Owen Yu-Hwa Huang Richard S Blumberg Nicole Beauchemin

Oncoimmunology 2017;6(7):e1328336. Epub 2017 May 16.

Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada.

View Article and Find Full Text PDF
May 2017